Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/9360
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Busuttil, Bridget E | en |
dc.contributor.author | Turney, K L | en |
dc.contributor.author | Frauman, Albert G | en |
dc.date.accessioned | 2015-05-15T22:25:42Z | |
dc.date.available | 2015-05-15T22:25:42Z | |
dc.date.issued | 2001-12-01 | en |
dc.identifier.citation | Protein Expression and Purification; 23(3): 369-73 | en |
dc.identifier.govdoc | 11722172 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/9360 | en |
dc.description.abstract | For the first time soluble, full-length, recombinant, human thyroid-stimulating hormone (TSH) receptor (TSHR) has been expressed in a prokaryotic system. The full-length TSHR cDNA, obtained from normal human thyroid, was cloned into a pQE-9 vector, sequenced, and confirmed to be identical to the published sequence, to be full length, and to be in frame. Expression of the receptor was as a fusion protein with a hexahistidine tail at the amino terminal, in an Escherichia coli expression system. Approximately 2.5 mg of protein per liter of bacterial culture was recovered from the cell homogenate, after a single passage through a nickel-nitrilotriacetic acid resin column. An estimated 60% increase in purity of a band of expected size, 87 kDa, was observed upon gel electrophoresis and staining with Coomassie blue, after the single purification step. Immunoreactivity of the 87-kDa protein with Graves' sera was confirmed by Western blotting. | en |
dc.language.iso | en | en |
dc.subject.other | Amino Acid Sequence | en |
dc.subject.other | Autoantibodies.immunology | en |
dc.subject.other | Blotting, Western | en |
dc.subject.other | Chromatography, Affinity | en |
dc.subject.other | Escherichia coli.genetics | en |
dc.subject.other | Gene Expression | en |
dc.subject.other | Graves Disease.immunology | en |
dc.subject.other | Histidine.metabolism | en |
dc.subject.other | Humans | en |
dc.subject.other | Receptors, Thyrotropin.genetics.immunology.isolation & purification.metabolism | en |
dc.subject.other | Recombinant Fusion Proteins.isolation & purification.metabolism | en |
dc.subject.other | Solubility | en |
dc.title | The expression of soluble, full-length, recombinant human TSH receptor in a prokaryotic system. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Protein expression and purification | en |
dc.identifier.affiliation | Clinical Pharmacology and Therapeutics Unit, Department of Medicine, Austin and Repatriation Medical Centre, The University of Melbourne, Austin Campus, Heidelberg, Victoria, 3084, Australia | en |
dc.identifier.doi | 10.1006/prep.2001.1519 | en |
dc.description.pages | 369-73 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/11722172 | en |
dc.type.austin | Journal Article | en |
local.name.researcher | Frauman, Albert G | |
item.fulltext | No Fulltext | - |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | Clinical Pharmacology and Therapeutics | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.